Immix Biopharma Eulerpool Новини

Immix Biopharma Eulerpool News

Immix Biopharma Новини за акции

Immix Biopharma се наблюдава от множество журналисти и инвеститори по целия свят. Най-актуалните Immix Biopharma новини събираме тук.

• 3 октомври ·

  TipRanks
  Immix Biopharma’s Promising Therapeutic Candidate NXC-201 Fuels Buy Rating Amidst Strong Clinical and Financial Outlook
• 2 октомври ·

  Yahoo
  Immix Biopharma Advances CAR-T NXC-201 to Expansion Cohort Dose Level in U.S. AL Amyloidosis Trial NEXICART-2
• 2 октомври ·

  Thefly.com
  Immix Biopharma: Ex-US study of NXC-201 produced 92% ORR in r/r AL Amyloidosis
• 19 септември ·

  Yahoo
  Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board
• 29 август ·

  Yahoo
  Immix Biopharma Independent Director Acquires 2.6% More Stock
• 28 август ·

  Yahoo
  Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2
• 28 август ·

  Thefly.com
  Immix Biopharma announces three more sites for NEXICART-2 trial
• 19 август ·

  Yahoo
  What Makes Immix Biopharma (IMMX) a New Buy Stock
• 19 август ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX)
• 12 август ·

  InvestorPlace
  IMMX Stock Earnings: Immix Biopharma Beats EPS for Q2 2024